An Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patients

Hdl Handle:
http://hdl.handle.net/10147/558633
Title:
An Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patients
Authors:
Twomey, F; O Brien, T; O’Reilly, M; Bogan, C; Fleming, J
Publisher:
Irish Medical Journal
Journal:
Irish Medical Journal
Issue Date:
Jun-2015
URI:
http://hdl.handle.net/10147/558633
Item Type:
Article
Language:
en
Description:
Breakthrough cancer pain (BTcP) is common, resulting in significant physical and psychosocial morbidity. We assessed the impact of BTcP on 81 cancer patients attending Irish specialist palliative care services. BTcP occurred up to twice daily in 24 (30%) and 3-4 times daily in 57 (70%) of cases. Median scores for the â worstâ and â leastâ pains in the previous 24 hours were 7 and 2/10 respectively. Pain lasted <15 minutes in 19 (23.5%), 15â 30 minutes in 25 (30.8%), 30â 60 minutes in 18 (22.2%) and > 60 minutes in 19 (23.5%) of patients. BTcP had a negative impact on general activity, mood, walking ability, work, relations with others, sleep and overall enjoyment of life. BTcP increased anxiety, depression, anger, isolation, financial difficulties and an inability to undergo cancer treatments. Systematic assessment of BTcP should form an integral part of every oncology/palliative medicine assessment. Once identified, BTcP should be managed assiduously.
Keywords:
PALLIATIVE CARE; CANCER
Local subject classification:
BREAKTHROUGH CANCER PAIN (BTcP)

Full metadata record

DC FieldValue Language
dc.contributor.authorTwomey, Fen
dc.contributor.authorO Brien, Ten
dc.contributor.authorO’Reilly, Men
dc.contributor.authorBogan, Cen
dc.contributor.authorFleming, Jen
dc.date.accessioned2015-06-29T14:30:16Zen
dc.date.available2015-06-29T14:30:16Zen
dc.date.issued2015-06en
dc.identifier.urihttp://hdl.handle.net/10147/558633en
dc.descriptionBreakthrough cancer pain (BTcP) is common, resulting in significant physical and psychosocial morbidity. We assessed the impact of BTcP on 81 cancer patients attending Irish specialist palliative care services. BTcP occurred up to twice daily in 24 (30%) and 3-4 times daily in 57 (70%) of cases. Median scores for the â worstâ and â leastâ pains in the previous 24 hours were 7 and 2/10 respectively. Pain lasted <15 minutes in 19 (23.5%), 15â 30 minutes in 25 (30.8%), 30â 60 minutes in 18 (22.2%) and > 60 minutes in 19 (23.5%) of patients. BTcP had a negative impact on general activity, mood, walking ability, work, relations with others, sleep and overall enjoyment of life. BTcP increased anxiety, depression, anger, isolation, financial difficulties and an inability to undergo cancer treatments. Systematic assessment of BTcP should form an integral part of every oncology/palliative medicine assessment. Once identified, BTcP should be managed assiduously.en
dc.language.isoenen
dc.publisherIrish Medical Journalen
dc.subjectPALLIATIVE CAREen
dc.subjectCANCERen
dc.subject.otherBREAKTHROUGH CANCER PAIN (BTcP)en
dc.titleAn Observational Research Study to Evaluate the Impact of Breakthrough Cancer Pain on the Daily Lives and Functional Status of Patientsen
dc.typeArticleen
dc.identifier.journalIrish Medical Journalen
All Items in Lenus, The Irish Health Repository are protected by copyright, with all rights reserved, unless otherwise indicated.